Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review

被引：9

作者：

Serban, Dragos ^{[1
,2
]}

Costea, Daniel Ovidiu ^{[3
,4
]}

Zgura, Anca ^{[5
,6
]}

Tudosie, Mihail Silviu ^{[7
,8
]}

Dascalu, Ana Maria ^{[9
,10
]}

Gangura, Gabriel Andrei ^{[1
,11
]}

Smarandache, Catalin Gabriel ^{[1
,2
]}

Sabau, Alexandru Dan ^{[12
,13
]}

Tudor, Corneliu ^{[2
]}

Faur, Mihai ^{[12
,13
]}

Costea, Andreea Cristina ^{[14
]}

Stana, Daniela ^{[10
]}

Balasescu, Simona Andreea ^{[2
]}

Tribus, Laura Carina ^{[15
,16
]}

Tanasescu, Ciprian ^{[12
,13
]}

机构：

[1] Carol DavilaUniv Med & Pharm, Dept Gen Surg, Fac Med, Bucharest, Romania

[2] Emergency Univ Hosp, Dept Surg Emergency 4, Bucharest, Romania

[3] Ovidius Univ, Fac Med, Dept Clin Surg Disciplines 1, Constanta, Romania

[4] Emergency Cty Hosp, Surg Dept 1, Constanta, Romania

[5] Carol DavilaUniv Med & Pharm, Fac Med, Dept Oncol Radiol & Hematol, Bucharest, Romania

[6] Inst Oncol Prof Dr Alexandru Trestioreanu, Dept Oncol Radiotherapy, Bucharest, Romania

[7] Carol Davila Univ Med & Pharm, Fac Med, Dept Orthopedia & Intens Care, Bucharest, Romania

[8] Clin Emergency Hosp, ICU Toxicol 2, Bucharest, Romania

[9] Carol Davila Univ Med & Pharm, Fac Med, Dept ENT Ophthalmol, Bucharest, Romania

[10] Emergency Univ Hosp, Ophthalmol Dept, Bucharest, Romania

[11] Emergency Univ Hosp, Dept Surg 2, Bucharest, Romania

[12] Lucian Blaga Univ, Fac Med, Surg Clin Dept, Sibiu, Romania

[13] Sibiu Cty Emergency Clin Hosp, Dept Surg, Sibiu, Romania

[14] Diaverum Clin, Nephrol & Dialysis Dept, Constanta, Romania

[15] Carol Davila Univ Med & Pharm, Dept Internal Med Gastroenterol, Fac Med, Bucharest, Romania

[16] Emergency Univ Hosp Bucharest, Gastroenterol Dept, Bucharest, Romania

来源：

IN VIVO | 2022年 / 36卷 / 01期

关键词：

Breast cancer; endocrine therapy; aromatase inhibitors; ocular side-effects; dry eye; anastrozole; review; DRY-EYE SYNDROME; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; TAMOXIFEN THERAPY; RANDOMIZED-TRIAL; SURFACE DISEASE; ANASTROZOLE; ESTROGEN; LETROZOLE; EXEMESTANE;

D O I：

10.21873/invivo.12674

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

in patients with breast cancer. Materials and Methods: A comprehensive search was performed on PubMed, Web of Science and Google scholar. Results: After duplication removal, 14 clinical studies and 5 case reports, published between 2008 and 2021, were identified. Most frequently, AI treatment resulted in minor to moderate dry eye symptoms. "De novo" onset of Sjogren syndrome during AI therapy was also reported. Retinal and optic nerve side effects varied from mild, subclinical anatomic and functional impairment to severe decreased vision, secondary to hemi-central retinal artery occlusion, bilateral optic neuritis or uveitis with bilateral macular edema. Conclusion: Visual disturbances encountered during AI treatment may be underestimated. Ophthalmic screening is important for early detection and appropriate treatment.

引用

页码：40 / 48

页数：9

共 50 条

[31] Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors
Boskovic, Lidija
Gasparic, Maja
Petkovic, Marija
Gugic, Damir
Lovasic, Ingrid Belac
Soldic, Zeljko
Mise, Branka Petric
Dabelic, Nina
Vazdar, Ljubica
Vrdoljak, Eduard
BREAST, 2017, 31 : 16 - 19
[32] Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review
Charehbili, A.
Fontein, D. B. Y.
Kroep, J. R.
Liefers, G. J.
Mieog, J. S. D.
Nortier, J. W. R.
van de Velde, C. J. H.
CANCER TREATMENT REVIEWS, 2014, 40 (01) : 86 - 92
[33] Current Opinion of Aromatase Inhibitor-induced Arthralgia in Breast Cancer in the UK
Din, O. S.
Dodwell, D.
Winter, M. C.
Mori, S.
Coleman, R. E.
CLINICAL ONCOLOGY, 2011, 23 (10) : 674 - 680
[34] Adherence to Adjuvant Aromatase Inhibitor Therapy Among Postmenopausal Hispanic/Latino Women With Breast Cancer
Philipovskiy, Alexander
Campbell, Aleli
Heydarian, Rosalinda
Castillo, Brenda
Dwivedi, Alok K.
Mccallum, Richard
Aguilera, Renato
Gaur, Sumit
Nahleh, Zeina
ANTICANCER RESEARCH, 2020, 40 (02) : 857 - 864
[35] Racial Differences in Depressive Symptoms and Self-Rated Health Among Breast Cancer Survivors on Aromatase Inhibitor Therapy
Calhoun, Carla
Helzlsouer, Kathy J.
Gallicchio, Lisa
JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 2015, 33 (03) : 263 - 277
[36] Neoadjuvant Endocrine Therapy for Breast Cancer
Chawla, Jane S.
Ma, Cynthia X.
Ellis, Matthew J.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 627 - +
[37] Adjuvant aromatase inhibitor therapy for early breast cancer: A review of the most recent data
Grana, G.
JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (07) : 585 - 592
[38] Neoadjuvant endocrine therapy in breast cancer
Abrial, C
Mouret-Reynier, MA
Curé, H
Feillel, V
Leheurteur, M
Lemery, S
Le Bouëdec, G
Durando, X
Dauplat, J
Chollet, P
BREAST, 2006, 15 (01) : 9 - 19
[39] Safety of aromatase inhibitor therapy in breast cancer
Lintermans, Anneleen
Neven, Patrick
EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1201 - 1211
[40] Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India
Butani, Dimple
Gupta, Nidhi
Jyani, Gaurav
Bahuguna, Pankaj
Kapoor, Rakesh
Prinja, Shankar
BREAST CANCER-TARGETS AND THERAPY, 2021, 13 : 625 - 640

← 1 2 3 4 5 →